Antiemetics MarketSize And Forecast
According to Verified Market Research, the Antiemetics Market was valued at USD 4.15 Billion in 2018 and is projected to reach USD 6.7 Billion by 2026, growing at a CAGR of 6.24% from 2019 to 2026.
Global Antiemetics Market Outlook
The global antiemetics market is majorly driven by increasing number of cancer patients globally. As chemotherapy is used for the treatment of cancer causes the side effects such as nausea and vomiting which in turn supports the usage of antiemetic drugs. According to World Health Organization report 2018, the incidence of cancer has risen to 18.1 million and 9.6 million deaths globally. Moreover, the rising number of gastroenteritis patients further foster the growth of global antiemetics market. On the other hand, lack of awareness regarding the variety of antiemetic and antinauseant drugs which are available in the market among the practitioners that might impede the market growth.
Global Antiemetics Market Competitive Landscape
The Global Antiemetics Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Pfizer, GlaxoSmithCline, Eli Lilly and Company, Merck, Sanofi-Aventis, Bristol-Myers Squibb, Baxter International, Astellas Pharma, and Johnson & Johnson.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.